Immune checkpoint blockade PD-1 therapy for primary liver cancer: incidence and influencing factors of thyroid dysfunction

OBJECTIVES: To investigate the incidence and influencing factors of thyroid dysfunction (TD) in patients with primary liver cancer (PLC) induced by PD-1 monoclonal antibodies. METHODS: Clinical data were collected from 195 PLC patients treated with PD-1. They were divided into TD group and normal th...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Huili, Xiong, Fang, Bao, Xuli, Lu, Jun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9798708/
https://www.ncbi.nlm.nih.gov/pubmed/36581947
http://dx.doi.org/10.1186/s13027-022-00476-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9798708/
https://www.ncbi.nlm.nih.gov/pubmed/36581947
http://dx.doi.org/10.1186/s13027-022-00476-6

Ejemplares similares